For citations:

Belousov D.Yu., Cheberda A.E., Afanasyeva E.V., Gladkov O.A. Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2018;(2):13-28. (In Russ.) https://doi.org/10.24411/2588-0519-2018-10041